That's where Alzheimer's patients have a buildup of toxic proteins called amyloid.

在这个部分，阿尔茨海默病患者积累了一种叫做淀粉样蛋白有毒蛋白质。

Higher deposition of amyloid goes hand-in-hand trade loss of function in Alzheimer's disease.

淀粉样蛋白高度沉积与阿尔茨海默病患者功能丧失密切相。

The new technique looks for protein called amyloid beta that associated with the condition. Our health correspondent James Galiga reports.

这项技术是要寻找一个被称为淀粉状β肽蛋白质，该物质与阿尔兹海默病有。下是我台医疗者吉姆斯·加里道。

Look at the texture -- the amyloid plaques.

太恶心了。

High amyloid is associated with conditions other than Alzheimer's.

高淀粉样蛋白和阿兹海默症状况没系吧。

Familial amyloid cardiomyopathy is a genetic disorder where mutant transthyretin protein, or TTR, is misfolded and prone to depositing in the heart tissue.

突变转甲状腺素蛋白（TTR）折叠错误，并易于在心脏组织中沉积。

Amyloids are proteins that have been misfolded, and once misfolded they become insoluble and can deposit in various tissues and organs, making them less compliant.

淀粉样蛋白是错误折叠蛋白质，一旦折叠错误，它们就变得不可溶；这些蛋白可沉积在很多组织和器官当中，让其顺应性变差。

A hallmark of Alzheimer's disease is the build up of a peptide called amyloid beta, and the glymphatic system helps clear this stuff out of the brain.

阿兹海默症一个特点是一种叫做β淀粉样蛋白缩氨酸累积，而类淋巴系统则有助于将这种物质清除出大脑。

Research has found that hemoglobin and heme itself help reduce inflammation in the brain and clear out the problematic amyloid plaques found in the brain of Alzheimer's patients.

研究发现，血红蛋白和血红素本身有助于减少大脑中炎症，清除阿尔茨海默病患者大脑中存在有问题淀粉样蛋白斑块。

The study used brain scans and samples of spinal fluid to look at the biological hallmarks of Alzheimer's, amyloid plaques and tangles made up of proteins called tau.

这项研究利用脑部扫描和脊髓液样本来观察阿尔茨海默氏症生物学特征、淀粉样斑块和由tau蛋白构成缠结。

Now, along with insulin, beta cells also secrete islet amyloid polypeptide, or amylin, so while beta cells are cranking out insulin they also secrete an increased amount of amylin.

同时，除胰岛素外，β细胞也会分泌胰岛淀粉样多肽（胰淀素），所当β细胞分泌更多胰岛素时，它们也分泌了更多胰淀素。

The new approach reported in the journal Nature looks for fragments of amyloid that end up in the blood stream. Trials on nearly 400 people show it's more 90% accurate.

这项发表于《自然》期刊上新方法是要寻找最终停留在血液里淀粉状蛋白片段。对400人进行试验表明其准确率超过90%。